Edwards Lifesciences Investments Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 136.11  1.79  1.33%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Investments of Edwards Lifesciences Corporation with missing and latest data points interpolated. A component of Total Assets representing the total amount of marketable and non-marketable securties, loans receivable and other invested assets.
Investments  10 Years Trend  
Increasing
Slightly volatile
 Investments 
      Timeline 

Edwards Lifesciences Investments Over Time

2016-12-31  873,100,000 
2017-12-31  873,100,000 
2018-12-31  925,947,368 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  454,003,644
Geometric Mean  217,109,560
Coefficient Of Variation  89.74
Mean Deviation  369,019,309
Median  301,100,000
Standard Deviation  407,401,169
Range  1,003,600,000
R Value  0.90
R Squared  0.81
Significance  0.00002462
Slope  94,380,682

Currently Trending

V   
 NYQ 
Sold over 20 shares of
few hours ago ago
Traded for 121.85
S   
 NYQ 
Purchased over 500 shares of
few hours ago ago
Traded for 5.39
F   
 NYQ 
Purchased over 200 shares of
few hours ago ago
Traded for 10.61